In type 1 diabetes (T1DM) and T2DM sclerostin levels were found to be higher compared to non-diabetic controls [10, 11, 29] which might be due to an impaired suppression of sclerostin production by PTH in patients with diabetes [29]. This evidence concerns the gene SOST and type 1 diabetes mellitus.